Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Mdaw94on Apr 29, 2019 10:18pm
87 Views
Post# 29686657

RE:RE:RE:RE:Congratulations

RE:RE:RE:RE:Congratulations
mozzarella wrote:
Canopy standing on tooth pics for legs that stock price ready to crumble like it did before....

Homestretch4me wrote: Who wants to buy canopy at $70?

I'm not sure, let's take a look. Today, both stocks trading volume was approximately 18,000,000 shares Aurora at $12.18 and up 3 cents and Canopy at $69.90 and up $2.76 cents. Seems to me everyone wants Canopy at $70 except for the people that cant afford it. Tell me again how many shares has your hopeful CCO sold lately??
Jessuzo wrote: Thats a real nice mathematic analysis but your conclusion is quite wrong. We can see a 3,4,5 dollar day, its just going to take time. Just like when Canopy was at 10$ they didnt see such days even if dilution wasnt a factor and that the total of shares out wasn’t as high as Aurora’s right now. But the thing is, yes having such dilution (1billion shares out) will slow down the SP from rising in the short term. But in the long term, I truely believe this company will have a bigger market cap than Canopy’s. If we had an SP at 70$ like Canopy (which is not realistic right now of course), market cap would be around 70 billion, more than twice Canopy’s. Patience is key, I believe ACB’s team know what they are doing and that in time, they will become the “megalodeon” and take Canopy’s spot at #1. Remember that Vivien Azer (analyst from Cowen) replaced Canopy with Aurora for his favorite top 1 pot stock. Some people said it was just bullish news to hype the stock at the time, but I say he just sees a futur others cant understand for this company. Who wants to buy Canopy at 70$ right now? Its way to high when other stocks are way cheaper. Yes they took the lead, but there not going to get the momentum ACB will be getting in the months/years to come, as will other pot stocks. I really have no doubts on ACB on the long run (recession, law changes or any other unlikely misfortune not accounted for).

 



You can’t buy Canapy now at 70 that’s ridiculous. Not the price of the share but the chance for it to even double. Buy the time there warrants and options are factored in fully  deluted if Canopy were to double in say a year warrants and options in market cap would have to be 75 billion-ish. Not happening with no international medical sales. Not even EU GMP certified. Tying up 3 billion in newly printed shares to sit in escrow until Pat Robertson or some other pyshco cult leader tells Trump it’s ok to legalize . Not the safest bet for next few years. Sure there getting a little juice now from the retail investors hype. Bruce Linton is the king of hype PRs. Like the time he asked iiroc to halt Canopy’s stock then called a press conference to say they put plants on a plane lol. Aurora will triple before doubles ..all imo ofcourse 

Bullboard Posts